| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis
|
Qiu, Shanhu
|
|
2017
|
10 |
9 |
p. 701-713
|
article
|
| 2 |
Clinical performance of an infliximab rapid quantification assay
|
Magro, Fernando
|
|
2017
|
10 |
9 |
p. 651-660
|
article
|
| 3 |
Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population
|
Delgado-Herrera, Leticia
|
|
2017
|
10 |
9 |
p. 673-687
|
article
|
| 4 |
Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
|
Cash, Brooks D.
|
|
2017
|
10 |
9 |
p. 689-699
|
article
|
| 5 |
The global impact of IBS: time to think about IBS-specific models of care?
|
Corsetti, Maura
|
|
2017
|
10 |
9 |
p. 727-736
|
article
|
| 6 |
The impact of panenteric capsule endoscopy on the management of Crohn’s disease
|
Eliakim, Rami
|
|
2017
|
10 |
9 |
p. 737-744
|
article
|
| 7 |
The place of eluxadoline in the management of irritable bowel syndrome with diarrhea
|
Levio, Sherry
|
|
2017
|
10 |
9 |
p. 715-725
|
article
|
| 8 |
Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays
|
Afonso, Joana
|
|
2017
|
10 |
9 |
p. 661-671
|
article
|
Journal description